Sustainability Life sciences faces a battle with sustainability, but let’s ... We know that the global healthcare sector is a contributor to the warming of our planet.
Views & Analysis Increasing sustainability in pharma requires an industry-wid... With COP27 concluding in November, Ben Hargreaves takes a look at what efforts pharma companies are making to limit their environmental impact.
News Supporting the era of green pharmaceuticals in the UK According to a report by the Office of Health Economics (OHE), commissioned by the Association of th
Views & Analysis It’s time get real with healthcare's commitment to net zero Every fraction of a degree matters
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.